Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (SHG:605016) — Market Cap & Net Worth
Market Cap & Net Worth: Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016)
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (SHG:605016) has a market capitalization of $1.34 Billion (CN¥9.13 Billion) as of August 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #7680 globally and #1711 in its home market, demonstrating a -3.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s stock price CN¥21.74 by its total outstanding shares 420012320 (420.01 Million). See 605016 capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Market Cap History: 2021 to 2026
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market capitalization history from 2021 to 2026. Data shows growth from $1.08 Billion to $1.34 Billion (14.69% CAGR).
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.96x
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market cap is 0.96 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.60x
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market cap is 3.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.08 Billion | $653.36 Million | $104.48 Million | 1.65x | 10.32x |
| 2022 | $933.94 Million | $721.89 Million | $150.75 Million | 1.29x | 6.20x |
| 2023 | $1.72 Billion | $868.26 Million | $193.00 Million | 1.99x | 8.93x |
| 2024 | $1.04 Billion | $1.15 Billion | $245.60 Million | 0.90x | 4.23x |
| 2025 | $1.33 Billion | $1.38 Billion | $368.55 Million | 0.96x | 3.60x |
Competitor Companies of 605016 by Market Capitalization
Companies near Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. in the global market cap rankings as of August 7, 2026.
Key companies related to Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. by market ranking:
- Nestlé S.A (F:NESM): Ranked #84 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #91 globally with a market cap of $214.29 Billion USD ( CHF169.50 Billion CHF).
- Danone SA (PA:BN): Ranked #521 globally with a market cap of $51.26 Billion USD ( €43.85 Billion EUR).
- Danone SA (F:BSND): Ranked #695 globally with a market cap of $39.05 Billion USD ( €33.40 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Nestlé S.A | F:NESM | $224.33 Billion | €87.60 |
| #91 | Nestle S.A. | SW:NESN | $214.29 Billion | CHF81.12 |
| #521 | Danone SA | PA:BN | $51.26 Billion | €68.16 |
| #695 | Danone SA | F:BSND | $39.05 Billion | €13.20 |
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market cap moved from $1.08 Billion to $ 1.34 Billion, with a yearly change of 14.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.34 Billion | +0.65% |
| 2025 | CN¥1.33 Billion | +27.81% |
| 2024 | CN¥1.04 Billion | -39.74% |
| 2023 | CN¥1.72 Billion | +84.55% |
| 2022 | CN¥933.94 Million | -13.40% |
| 2021 | CN¥1.08 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 7th, 2026 the market cap of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.34 Billion USD |
| MoneyControl | $1.34 Billion USD |
| MarketWatch | $1.34 Billion USD |
| marketcap.company | $1.34 Billion USD |
| Reuters | $1.34 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more